Health Teclistamab extends remission in relapsed myeloma, with 70% progression-free at 18 months No Redakcija - May 30, 2026 🛡️ Just a quick check We’re checking your connection to prevent automated abuse Read More Share this: Share on Facebook (Opens in new window) Facebook Share on X (Opens in new window) X
